GZ/SAR402671

FDA Grants Fast Track Designation to Genzyme’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease
Yahoo
Tue, 04/28/15 - 08:50 am
FDA
fast track
Genzyme
Fabry's disease
GZ/SAR402671
Sanofi